TickerFacts.

Company research / BRKR

Bruker Corp (BRKR)

Also trades as BRKRP. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

SEC name BRUKER CORP · CIK 0001109354 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Bruker Corp reported revenue of $3.44B. Revenue grew 2.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $3.50B.

Key ratios (year ended 2025-12-31)

45.9%
Gross margin
2.0%
Operating margin
-0.2%
Net margin
-0.3%
Return on year-end equity
2.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$3.50B$3.44B$3.37B$2.96B$2.53B$2.42B$1.99B$2.07B$1.90B$1.77B$1.61B
Cost of Revenue$1.88B$1.86B$1.72B$1.45B$1.23B$1.21B$1.05B$1.08B$995.60M$949.90M$866.00M
Gross Profit$1.62B$1.58B$1.65B$1.51B$1.31B$1.21B$939.80M$995.30M$900.00M$816.00M$745.30M
R&D Expense$393.50M$395.20M$376.50M$294.80M$235.90M$220.80M$198.00M$187.70M$173.40M$161.60M$147.90M
Operating Income-$30.60M$68.20M$253.10M$436.90M$432.70M$413.30M$248.30M$300.90M$262.40M$219.50M$181.80M
Depreciation & Amortization$230.10M$220.30M$183.80M$114.90M$88.80M$89.10M$80.40M$75.60M$64.90M$63.90M$54.30M
EBITDA$199.50M$288.50M$436.90M$551.80M$521.50M$502.40M$328.70M$376.50M$327.30M$283.40M$236.10M
Net Income-$64.50M-$8.30M$113.80M$428.50M$298.50M$280.60M$161.40M$198.00M$181.00M$80.30M$154.50M
EPS (Diluted)n/a-$0.15$0.76$2.90$1.99$1.81$1.02$1.26$1.14$0.49$0.95
Total Assets$6.05B$6.24B$5.81B$4.25B$3.61B$3.65B$3.05B$2.77B$2.13B$1.95B$1.81B
Total Liabilitiesn/a$3.73B$3.99B$2.84B$2.48Bn/an/an/an/an/an/a
Long-Term Debt$1.82B$1.87B$2.09B$1.28B$1.22B$1.33B$844.50M$813.30M$341.10Mn/an/a
Shareholders' Equity$2.40B$2.47B$1.80B$1.39B$1.13B$1.08B$974.30M$917.10M$905.10M$733.50M$693.10M
Cash & Equivalents$184.90M$298.80M$183.40M$488.30M$645.50M$1.07B$681.80M$678.30M$322.40M$325.00M$342.40M
Operating Cash Flow$190.40M$134.10M$251.30M$350.10M$274.40M$282.40M$332.20M$213.40M$239.70M$154.40M$130.80M
Capital Expenditures$96.50M$90.80M$115.30M$106.90M$129.20M$92.00M$97.20M$73.00M$49.20M$43.70M$37.10M
Free Cash Flow$93.90M$43.30M$136.00M$243.20M$145.20M$190.40M$235.00M$140.40M$190.50M$110.70M$93.70M
Share Repurchasesn/a$10.00M$0$152.30M$263.10M$153.30M$123.20M$142.30Mn/a$152.20M$160.00M
Dividends Paid$22.60M$22.80M$30.20M$29.40M$29.80M$24.20M$24.60M$25.00M$25.10M$25.40M$25.80M
Shares Outstanding152.35M152.14M151.68M145.16M147.02M150.75M151.99M154.16M156.61M155.87M159.85M
Dividends Per Sharen/an/a$0.20$0.20$0.20$0.16$0.16$0.16$0.16$0.16$0.16
Weighted Average Diluted Sharesn/a151.80M149.50M147.20Mn/an/a154.60M156.60M157.20M159.10M162.20M
EPS (Basic)n/a-$0.15$0.76$2.92$2.00$1.83$1.03$1.27$1.15$0.50$0.95

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView